arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

Nano Labs Ltd

$1.41 ▼ -0.09 (-6.33%) at close

6 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bullish

auto_awesome

Analytical Summary

Nano Labs Ltd shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $28.0M

Dividend Yield —

Revenue Growth -32.0% ↗

Op. Margin None

ROIC 6.1% ↗

FCF / Share $-0.78 ↗

Trailing P/E 1.5x

Price / Book 0.3x

FCF Yield —

Debt / Equity 0.29

info Valuation on last close. End-of-day price, Nov 5, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.84M

↓ -32.0% —

Net Income Profit after all expenses

$19.27M

↑ +222.4% —

Operating Margin Operating profit as % of sales

-242.7%

↑ +27.1% —

FCF / Share Free cash flow per share

$-0.78

↑ +74.4% —

Long-Term Debt Long-term obligations

$24.31M

↑ +2.4% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↓

Returns →

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗
Revenue Growth YoY (%)	-32.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-366%)	-48.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-508%)	-92.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-868%)	—	—	—
EPS Growth YoY (%)	N/M	-221.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—
Net Income Growth YoY (%)	N/M	55.9% Excellent Excellent Year-over-year change in net income	N/M	—	—	—
FCF Growth YoY (%)	74.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-430.0% Weak Weak Year-over-year change in free cash flow	-45.3% Weak Weak Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	-69.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
EPS CAGR 3Y (%)	189.4% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗
Operating Margin (%) (%)	—	-242.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1313%)	-332.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1765%)	2.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-89%)	—	—
Effective Tax Rate (%) (%)	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	-278.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1959%)	-322.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2252%)	3.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	—	—
FCF Margin (%) (%)	-401.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-432.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-305.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-29.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	-0.80x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.55x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-9.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗
Return on Invested Capital (%)	6.1% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-247.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	6.4% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-74.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	5.6% Caution Caution Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	18.1% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-49.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	—	18.9% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗
Debt to Equity (x)	0.29x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-36%)	0.82x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+82%)	-9.52x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-2216%)	—	—	—
Interest Coverage (x)	6.75x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	-10.61x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-69.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	114.52x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$29.22M	$21.74M	$13.00M	$-12.61M	—	—
Debt / EBITDA (x)	3.00x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.92x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.55x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗
Revenue per Share (USD)	$0.19	$0.70	$0.19	$1.33	—	—
Basic EPS, GAAP (USD)	$0.97	$-1.96	$-0.61	$0.04	—	—
Free Cash Flow per Share (USD)	$-0.78	$-3.04	$-0.57	$-0.39	—	—
Book Value per Share (USD)	$5.36	$3.99	$-0.04	$0.21	—	—
Tangible Book Value per Share (USD)	$5.36	$3.99	$-0.04	$0.21	—	—
Basic Weighted Avg Shares (shares)	19.86M	8.05M	58.89M	106.49M	89.88M	79.25M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗
Working Capital (USD)	$31.99M	$21.87M	$-16.53M	$15.08M	—	—
LT Debt (USD)	$24.31M	$23.74M	$16.98M	—	—	—
Total Equity (USD)	$106.46M	$32.11M	$-2.08M	$23.61M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗
Sales/Revenue/Turnover (USD)	$3.84M	$5.65M	$11.06M	$141.17M	—	—
Depreciation Expense (USD)	—	—	$624.42K	$564.01K	—	—
Net Income, GAAP (USD)	$19.27M	$-15.75M	$-35.70M	$4.47M	—	—
Operating Cash Flow (USD)	$-15.40M	$-19.38M	$-18.85M	$-39.48M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 6 years · 5 quarters

Nano Labs Ltd

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NA with peers